MacroGenics Inc. (MGNX) News Headlines

▮ More

Date

Headline

9/28/2021 8:53:52 AM I-Mab Reports Acceptance Of IND Application In China For Phase 2 Trial With Enoblituzumab

2/11/2021 4:42:22 PM MacroGenics Adds Federica O’Brien To Its Board

12/18/2020 7:54:10 AM MacroGenics Reaches Research Collaboration With Janssen; To Get Up To $332 Mln Payments

12/18/2020 7:37:16 AM MacroGenics Enters Research Collaboration, Global License Agreement With Janssen Biotech

12/16/2020 10:33:09 PM FDA Approves MacroGenics' Margenza For Pretreated Metastatic HER2-Positive Breast Cancer

11/29/2020 8:12:00 PM Biotech Stocks Facing FDA Decision In December 2020

11/8/2020 9:52:03 AM Week Ahead In Pharma: FDA Decisions, SITC Presentations, 13D SEC Filing

9/21/2020 7:31:36 AM MacroGenics Says $15 Mln Milestone Triggered By Initiation Of Phase 3 Trial In NSCLC By Incyte

6/16/2020 7:57:02 AM MacroGenics Appoints Stephen Eck As SVP, Clinical Development & Chief Medical Officer

6/5/2020 7:36:23 AM MacroGenics Says FDA Granted Orphan Drug Designation To Margetuximab

5/28/2020 11:35:21 PM ABIO Jumps On Joining COVID-19 Drug Fray, GMAB Hits Trial Goal, IMRA On Watch

5/28/2020 7:38:20 AM MacroGenics Provides Update On FDA Review Of Margetuximab; Says Advisory Committee Meeting Not Required

5/27/2020 7:36:19 AM MacroGenics Plans For Clinical Study Intended To Support Registration In US Of Flotetuzumab

5/13/2020 11:15:21 PM FDA Snubs BMY And BLUE, Stocks That Moved On ASCO Abstracts (ARVN, CTMX, MGNX)

5/6/2020 11:33:38 PM FDA Decision On BMY's Drug Postponed, ENTA's PBC Study Fails, MGNX Turns Heads

4/27/2020 12:44:38 AM MacroGenics Announces Presentation Of Flotetuzumab Translational Data At 2020 AACR Annual Meeting

7/18/2019 9:07:27 AM Wedbush Reiterates MacroGenics Inc. (MGNX) At Outperform With $27 Price Target

6/5/2019 8:51:53 AM Wedbush Reiterates MacroGenics Inc. (MGNX) At Outperform With $27 Up From $26 Price Target

5/16/2019 6:44:44 AM Wedbush Reiterates MacroGenics Inc. (MGNX) At Outperform With $26 Price Target

5/3/2019 8:39:47 AM Wedbush Ups MacroGenics Inc. (MGNX) To Outperform From Neutral With $26 Price Target

Macrogenics Inc. (MGNX)